Lmwx 60 Injection

Description

Lmwx 60 Injection contains Enoxaparin 60mg, a low molecular weight heparin (LMWH) used as an anticoagulant for the prevention and treatment of blood clots. It is commonly prescribed for patients at risk of deep vein thrombosis (DVT), pulmonary embolism (PE), or other thromboembolic disorders, including those undergoing surgery or immobilized due to illness.

This subcutaneous injectable formulation provides rapid and predictable anticoagulant effects, offering a safer alternative to unfractionated heparin with lower monitoring requirements.

Uses

• Prevention of deep vein thrombosis (DVT) in surgical or bedridden patients

• Treatment of DVT and pulmonary embolism (PE)

• Prevention of clot formation in acute coronary syndrome (ACS)

• Reducing risk of thromboembolic events in high-risk patients

• Suitable for patients with limited mobility or post-surgical recovery

How It Works

• Enoxaparin is a low molecular weight heparin that potentiates antithrombin III, inhibiting clotting factors Xa and IIa.

• Reduces formation of pathological blood clots while maintaining predictable anticoagulation.

• Subcutaneous administration ensures rapid absorption and effectiveness.

• Often requires less frequent monitoring than standard heparin therapy.

Benefits

• Effective in preventing and treating thromboembolic disorders

• Lower risk of heparin-induced thrombocytopenia (HIT) compared to unfractionated heparin

• Convenient subcutaneous injection for hospital or home use

• Predictable anticoagulant effect with less frequent blood monitoring

• Helps reduce complications related to surgery, immobility, or cardiovascular risk

Directions for Use

• Administer only under medical supervision.

• Inject subcutaneously as directed by a physician.

• Dosage depends on patient weight, clinical condition, and risk factors.

• Do not self-adjust the dose without consultation.

• Avoid intravenous or intramuscular injection unless specifically prescribed.

Safety Information

• Common side effects: mild pain, bruising, or redness at injection site.

• Serious side effects (rare): bleeding, thrombocytopenia, severe allergic reactions.

• Use with caution in patients with bleeding disorders, kidney impairment, or recent surgery.

• Avoid concomitant use of other anticoagulants or antiplatelet drugs unless prescribed.

• Seek immediate medical attention if unusual bleeding, excessive bruising, or severe pain occurs.